NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NINDS E-120-2020-2-EP-03 ADAPTABLE DUAL-TUNED OPTICALLY CONTROLLED ON-COIL AMPLIFIER FOR HIGH-FIELD MAGNETIC RESONANCE IMAGING SYSTEMS EP National Stage 21746288.6 Pending
NIAID E-001-2024-0-US-05 Viral Strain Serology Assays US 63/482,083 Expired
NIAID E-178-2022-0-US-01 EPSTEIN-BARR VIRUS GLYCOPROTEIN 42 IMMUNOGENS FOR VACCINATION AND ANTIBODY DISCOVERY US 63/482,143 Expired
NHLBI E-191-2020-0-CN-03 SYSTEMS AND METHODS FOR MITRAL VALVE REPLACEMENT CN National Stage 202180059611.1 Pending
NCATS E-232-2020-0-JP-01 MULTI-CYCLIC IRAK AND FLT3 INHIBITING COMPOUNDS AND USES THEREOF JP National Stage 2023-506197 Pending
NCI E-018-2023-0-US-01 METHODS OF DETECTING T CELL RECEPTOR CROSS-REACTIVITY US 63/481,757 Expired
NHLBI E-035-2022-0-PCT-02 PREPARATION OF ISOTOPICALLY LABELED KETOGLUTARATES AND METHODS OF HYPERPOLARIZATION THROUGH SIGNAL AMPLIFICATION BY REVERSIBLE EXCHANGE (SABRE) PCT PCT PCT/US2023/011640 Expired
CC E-048-2023-0-US-01 Computer-vision method for bronchoscope navigation referencing and 3D model registration US 63/481,689 Expired
NCI E-199-2022-0-US-01 HUMAN PAPILLOMAVIRUS AND VARICELLA-ZOSTER VACCINE ANTIGENS AND USES
THEREOF IN CANCER IMMUNOTHERAPY 		US 63/481,544 Expired
NCI E-184-2009-0-US-04 Combination Immunotherapy Compositions And Methods US CON 18/158,800 Pending
NIAID E-197-2023-1-US-03 ANTI-SARS-CoV-2 ANTIGEN BINDING POLYPEPTIDES, POLYPEPTIDE COMPLEXES AND METHODS OF USE THEREOF [COM5] US 63/481,368 Expired
NHLBI E-191-2020-0-US-06 SYSTEMS AND METHODS FOR MITRAL VALVE REPLACEMENT US National Stage 18/006,331 Pending
NICHD E-170-2020-0-US-03 TIME EFFICIENT MULTI-PULSED FIELD GRADIENT (MPFG) MRI WITHOUT CONCOMITANT GRADIENT FIELD ARTIFACTS US National Stage 18/017,150 Pending
NIA E-024-2022-0-PC-01 GINGERENONE A PRODRUGS AS SENOTHERAPEUTICS AND METHODS OF USE PCT PCT PCT/US2023/010962 Expired
NHLBI E-191-2020-0-EP-04 SYSTEMS AND METHODS FOR MITRAL VALVE REPLACEMENT EP National Stage 21845838.8 Pending
NCI E-172-2020-0-JP-01 HLA CLASS II-RESTRICTED DRB T CELL RECEPTORS AGAINST RAS WITH G12V MUTATION JP National Stage 2023-503124 Pending
NCI E-045-2022-0-PCT-02 Method of HLA loss Heterozygosity Detection in Liquid Biopsies PCT PCT PCT/US2023/060664 Expired
NIAID E-251-2016-0-US-05 METHODS OF DIAGNOSING AND TREATING CD55 DEFICIENCY, HYPERACTIVATION OF COMPLEMENT, ANGIOPATHIC THROMBOSIS AND PROTEIN LOSING ENTEROPATHY (CHAPLE), A NEWLY IDENTIFIED ORPHAN DISEASE US DIV 18/154,745 Pending
NCI E-058-2023-0-US-01 BICYCLIC CARBAMOYL PYRIDONE-BASED INTEGRASE STRAND TRANSFER INHIBITORS US 63/438,994 Expired
NINDS E-047-2023-0-US-01 Genetic control of MRI signal US 63/479,835 Expired
NEI E-203-2023-0-US-01 APPARATUS AND METHOD FOR EXTRACELLULAR IMPEDANCE SPECTROSCOPY OF EPITHELIA US 63/479,798 Expired
NCI E-165-2020-0-US-02 HLA CLASS II-RESTRICTED DRB T CELL RECEPTORS AGAINST RAS WITH G12D MUTATION US National Stage 18/015,776 Pending
NCI E-172-2020-0-US-02 HLA CLASS II-RESTRICTED DRB T CELL RECEPTORS AGAINST RAS WITH G12V MUTATION US National Stage 18/015,781 Pending
NINDS E-130-2022-3-JP-02 OXABICYCLOHEPTANES FOR MODULATION OF IMMUNE RESPONSE JP DIV 2023-003205 Pending
NCI E-165-2020-0-JP-01 HLA CLASS II-RESTRICTED DRB T CELL RECEPTORS AGAINST RAS WITH G12D
MUTATION 		JP National Stage 2023-502572 Pending
NIAID E-104-2020-0-CN-05 RSV VACCINE BEARING ONE OF MORE P GENE MUTATIONS CN National Stage 202180061234.5 Pending
NCI E-172-2020-0-AU-01 HLA Class-II Restricted DRB1*01:01 T-cell Receptors Against The RASG12V Mutation AU National Stage 2021309958 Pending
NCI E-051-2022-0-PCT-02 Predicting Patient Treatment Response and Resistance via Single-Cell Transcriptomics of their Tumors PCT PCT PCT/US2023/060416 Expired
NIBIB E-040-2023-0-US-01 INTUBATION SYSTEM AND CHAMBER TANK US 63/438,197 Expired
NCI E-172-2020-0-CA-01 HLA Class-II Restricted DRB1*01:01 T-cell Receptors Against The RASG12V Mutation CA National Stage 3185483 Pending
NHLBI E-206-2020-0-US-02 DEVICES AND METHODS FOR CERCLAGE OF LUMENAL SYSTEMS US CON 18/151,601 Pending
NHLBI E-011-2016-0-US-01 CLOSED-ENDED, LINEAR, DUPLEX ADENOASSOCIATED VIRUS DNA, AND USES THEREOF US CON 18/151,803 Abandoned
NIDDK E-032-2023-0-US-01 Sidechain Functionalized S-acylbenzamides With Anti-HIV Activity US 63/437,868 Expired
NCATS E-192-2022-0-US-01 SDR Assay: A General High Throughout Binding Assay Strategy Based On A Ligand-biased Structural Dynamics Response. US 63/479,085 Expired
NCATS E-057-2022-0-PC-01 ESTRADIOL PRODRUGS AND METHODS OF USE THEREOF PCT PCT PCT/US2023/060233 Expired
NCI E-059-2013-0-US-02 METHODS OF PRODUCING ENRICHED POPULATIONS OF TUMOR-REACTIVE T CELLS FROM TUMOR US CON 18/093,902 Pending
NCI E-165-2020-0-SG-01 HLA Class-II Restricted DRB T-cell Receptors Against The RASG12D Mutation SG National Stage 11202300142Y Pending
NCI E-172-2020-0-SG-01 HLA CLASS II-RESTRICTED DRB T CELL RECEPTORS AGAINST RAS
WITH G12V MUTATION 		SG National Stage 11202300139Y Pending
NHLBI E-144-2021-0-PC-01 Tissue Cutting Systems and Methods PCT PCT PCT/US2023/060223 Expired
NCI E-165-2020-0-CA-01 HLA Class-II Restricted DRB T-cell Receptors Against The RASG12D Mutation CA National Stage 3185241 Pending
NIAID E-088-2022-0-PC-01 Novel Immunogens For Influenza Virus Vaccines PCT PCT PCT/US2023/060130 Expired
NCI E-078-2020-0-EP-05 SIZE-DEPENDENT BRAIN AND LYMPHATIC DISTRIBUTION OF MACROMOLECULAR DRUG DELIVERY PLATFORM EP National Stage 21822452.5 Pending
NIAAA E-316-2013-0-US-03 Process for producing (R)-3-Hydroxybutyl (R)-3-Hydroxybutyrate US CON 18/149,300 Pending
NHLBI E-206-2020-0-CA-01 Devices And Methods For Cerclage Of Lumenal Systems CA National Stage 3184823 Pending
NHLBI E-054-2024-0-US-01 System and Method for Variable-flip-angle 3D Spiral-in-out TSE/SPACE Using Echo-reordering and Concomitant Gradient Compensation US 63/436,679 Expired
NEI E-071-2020-0-US-08 CYCLIC COMPOUNDS FOR USE IN TREATING RETINAL DEGENERATION US National Stage 18/014,045 Pending
NHGRI E-034-2022-0-PCT-02 GENE THERAPY CONSTRUCTS FOR THE TREATMENT OF PROPIONIC ACIDEMIA CAUSED BY MUTATIONS IN PROPIONYL-COA CARBOXYLASE ALPHA PCT PCT PCT/US2022/082527 Expired
NCI E-233-2014-0-US-23 METHODS OF ISOLATING T CELL RECEPTORS HAVING ANTIGENIC SPECIFICITY FOR A CANCER-SPECIFIC MUTATION US DIV 18/147,786 Pending
NCI E-046-2022-0-PCT-02 Neoantigen T Cell Therapy With Neoantigen Vaccination As A Combination Immunotherapy Against Cancer PCT PCT PCT/US2022/082579 Expired
NEI E-071-2020-0-JP-07 COMPOUND EMBODIMENTS FOR TREATING RETINAL DEGENERATION AND METHOD EMBODIMENTS OF MAKING AND USING THE SAME JP National Stage 2022-581456 Pending